NASDAQ:ORGO
Organogenesis Holdings Inc. Class A Stock News
$2.77
+0.0300 (+1.09%)
At Close: May 20, 2024
Organogenesis Holdings Inc. (ORGO) Q4 2021 Earnings Call Transcript
03:00am, Wednesday, 02'nd Mar 2022 The Motley Fool
ORGO earnings call for the period ending December 31, 2021.
Organogenesis (ORGO) Tops Q4 Earnings and Revenue Estimates
12:25am, Wednesday, 02'nd Mar 2022 Zacks Investment Research
Organogenesis (ORGO) delivered earnings and revenue surprises of 412.50% and 3.38%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Organogenesis (ORGO) Tops Q4 Earnings and Revenue Estimates
09:29pm, Tuesday, 01'st Mar 2022
Organogenesis (ORGO) delivered earnings and revenue surprises of 412.50% and 3.38%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Organogenesis Holdings Inc. (ORGO) CEO Gary Gillheeney on Q4 2021 Results - Earnings Call Transcript
08:21pm, Tuesday, 01'st Mar 2022
Organogenesis Holdings Inc. (ORGO) CEO Gary Gillheeney on Q4 2021 Results - Earnings Call Transcript
Sage Therapeutics, Inc. (SAGE) Reports Q4 Loss, Misses Revenue Estimates
12:45pm, Thursday, 24'th Feb 2022 Zacks Investment Research
Sage Therapeutics, Inc. (SAGE) delivered earnings and revenue surprises of 1.85% and 8.27%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stoc
Organogenesis (ORGO) Stock Jumps 7.4%: Will It Continue to Soar?
01:54pm, Wednesday, 16'th Feb 2022 Zacks Investment Research
Organogenesis (ORGO) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increa
Organogenesis (ORGO) Stock Jumps 7.4%: Will It Continue to Soar?
10:49am, Wednesday, 16'th Feb 2022
Organogenesis (ORGO) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increa
Organogenesis Holdings Inc. to Participate in Upcoming Investor Conferences in February
12:30pm, Friday, 11'th Feb 2022 GlobeNewswire Inc.
CANTON, Mass., Feb. 11, 2022 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of
Organogenesis Holdings Inc. to Participate in Upcoming Investor Conferences in February
07:30am, Friday, 11'th Feb 2022
CANTON, Mass., Feb. 11, 2022 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of p
Organogenesis Holdings Inc. to Report Fourth Quarter and Fiscal Year 2021 Financial Results on March 1, 2022
12:30pm, Monday, 07'th Feb 2022 GlobeNewswire Inc.
CANTON, Mass., Feb. 07, 2022 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of
Organogenesis Holdings Inc. to Report Fourth Quarter and Fiscal Year 2021 Financial Results on March 1, 2022
07:30am, Monday, 07'th Feb 2022
CANTON, Mass., Feb. 07, 2022 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of p
ORGO LAWSUIT ALERT: Levi & Korsinsky Notifies Organogenesis Holdings Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
09:35pm, Wednesday, 02'nd Feb 2022 Kwhen Finance
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Organogenesis Holdings Inc. of Class Action Lawsuit and Upcoming Deadline - ORGO
11:45pm, Thursday, 06'th Jan 2022 Kwhen Finance
Is Abbott (ABT) Stock Outpacing Its Medical Peers This Year?
02:40pm, Tuesday, 21'st Dec 2021 Zacks Investment Research
Here is how Abbott (ABT) and Organogenesis (ORGO) have performed compared to their sector so far this year.
Organogenesis Appoints Prathyusha Duraibabu to Board of Directors
12:00pm, Monday, 22'nd Nov 2021 GlobeNewswire Inc.
CANTON, Mass., Nov. 22, 2021 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of
